OP-ED: “THE MIDDLEMAN” IN DRUG PRICING
David Balto — former policy director of the Federal Trade Commission — argues that it’s time for us to hold PBMs accountable for their greedy and dangerous tactics. Time to Rein in the Drug-Industry Middlemen Exploiting Patients By David Balto This summer, lawmakers missed a big chance to lower the cost […]
